Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
NEW YORK, March 21, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Gigamon Inc. (NYSE:GIMO) securities between October 27, 2016 and January 17, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/gigamon-inc. There is no cost or obligation to you.
According to the complaint, throughout the class period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about Gigamon’s business, operations, and prospects, including that: (1) Gigamon was experiencing reduced product bookings in its North America West region; (2) several of Gigamon’s significant customers were deferring purchasing decisions into 2017; (3) Gigamon failed to properly include these trends in its financial guidance; and (4) as a result, Defendants’ statements about Gigamon’s business, operations, and prospects, including statements about its revenue guidance, were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Gigamon you have until March 28, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/gigamon-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
